Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Red Spot Interactive and Symplast Integrate their Software to Create a 360-Degree Patient Engagement Solution Driven by Practice ROI


JUPITER, Fla., Sept. 22, 2019 /PRNewswire-PRWeb/ -- Red Spot Interactive (RSI), a return on investment (ROI) driven patient acquisition and retention software platform supporting more than 30 medical practice management systems, has partnered with Symplast, the No. 1 mobile EHR/practice management system for plastic surgeons that delivers a HIPAA-secure cloud platform to more than 3,500 aesthetic users across the U.S. This partnership will give Symplast clients fully synchronized access to RSI's patient acquisition, engagement, and retention software.

"Symplast has solved a difficult problem for aesthetic practices by creating a mobile-based PM platform for the fast-paced and dynamic aesthetic practice," said Jason Tuschman, CEO and founder of Red Spot Interactive. "We appreciate the effort to solve such a problem, given our history, and look forward to allowing our mutual practices to be smarter and faster with respect to ROI-driven patient acquisition and management."

"This is more than just a simple software integration; Symplast is excited to partner with Red Spot Interactive," said Symplast CEO/CTO Facundo Formica. "Their robust ROI software delivers a tremendous need to our Symplast users regarding lead generation, analysis and full transparency between the very beginning of the patient journey throughout their entire lifecycle. This new integration reinforces the role that Symplast plays in aesthetic practices, serving as the data hub from which other ancillary, specialized softwares can seamlessly talk to in order to optimize a practice."

The integration will allow Symplast clients to:

Through Red Spot's integration, Symplast customers will be able to manage the entire patient acquisition and retention process by return on investment while increasing practice scale and decreasing workload and vendor costs/touchpoints.

 

SOURCE Red Spot Interactive


These press releases may also interest you

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...



News published on and distributed by: